Contact us at 914-666-4665

Dr. Daniel Cameron

Dr. Daniel Cameron is a board-certified physician and epidemiologist specializing in Lyme disease and tick-borne illnesses. He is a past president of ILADS and has contributed to Lyme disease treatment guidelines, with a clinical focus on diagnosis, testing limitations, and complex cases.

Dr. Daniel Cameron
Borrelia miyamotoi review

Borrelia Miyamotoi Review: North America Infection Guide

Borrelia Miyamotoi Review: North America Infection Guide In their article, “Human Borrelia miyamotoi Infection in North America,” Burde and colleagues discuss the frequency and location of infection in ticks and people, clinical presentation and complications, diagnosis, treatment, and prevention. Prevalence of B. miyamotoi B. miyamotoi-infected ticks have been reported throughout the northeastern, northern Midwestern, and

Borrelia Miyamotoi Review: North America Infection Guide Read More »

greenspace-ticks

Manicured greenspaces harbor infected ticks

Manicured greenspaces harbor infected ticks It was once thought that well-kept, manicured yards, for instance, were safe and free of ticks. No longer. As this study finds, ticks can be found even in the most well-groomed recreational spaces. In their study, “Ticks and Tick-Borne Pathogens in Recreational Greenspaces in North Central Florida, USA,” Bhosale and

Manicured greenspaces harbor infected ticks Read More »

Case report: Lyme neuroborreliosis triggers multiple strokes

Case report: Lyme neuroborreliosis triggers multiple strokes In their article, “A case report of unilateral cerebral vasculitis in adults: keep in mind Lyme neuroborreliosis,” Riescher and colleagues examine the case of a 58-year-old man “with recurrent strokes in the same vascular territory without CSF pleocytosis, reflecting an unusual first manifestation of [Lyme neuroborreliosis].”¹ The authors

Case report: Lyme neuroborreliosis triggers multiple strokes Read More »

NEW LYME DISEASE VACCINES

Lyme Disease Vaccines in Development: What to Know About Current Candidates

Lyme Disease Vaccines in Development: What to Know About Current Candidates In 1998, the first Lyme disease vaccine, LYMErix, was introduced but later withdrawn from the market after several years due to poor sales and unresolved safety concerns. The FDA did not confirm that the vaccine caused harm. Lyme disease vaccines are once again being

Lyme Disease Vaccines in Development: What to Know About Current Candidates Read More »

Man in hospital bed with neurologic symptoms from Babesia.

Neurologic complications of Babesia

Neurologic Babesia Symptoms: How Babesiosis Affects the Brain (and Is Missed) It’s not just fatigue or fever. Patients become confused—or unsteady. This is where Babesia affects the brain. Neurologic Babesia symptoms are more common than many expect—and may be severe in hospitalized patients. This is where Babesia infection extends beyond typical symptoms. In a study

Neurologic complications of Babesia Read More »

young woman in hospital with lyme disease and covid symptoms

Case study: Lyme disease in patient with Long COVID

Lyme Disease and Long COVID: A Case of Overlapping Symptoms Symptoms began months after COVID-19 infection Fatigue, brain fog, and autonomic symptoms developed Lyme disease was later identified as a contributing factor The World Health Organization defines Long COVID as symptoms that persist or develop at least 3 months after infection, lasting for at least

Case study: Lyme disease in patient with Long COVID Read More »

Investigators question the term “Australian Lyme”

Investigators question the term “Australian Lyme” The authors looked at patients admitted to their infectious disease clinic in Australia between 2014 – 2020. “Patients were included if they had debilitating symptoms suggested by either themselves or the referring clinician as being attributed to ticks.” They acknowledged that there are ill patients who have been seen

Investigators question the term “Australian Lyme” Read More »